We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Test Could Provide Snapshot of Overall Health

By LabMedica International staff writers
Posted on 09 Jul 2024
Print article
Image: Proteomic analysis of cardiorespiratory fitness for prediction of mortality and multisystem disease risks (Photo courtesy of Perry, A.S., Farber-Eger, E., Gonzales, T. et al.; doi.org/10.1038/s41591-024-03039-x)
Image: Proteomic analysis of cardiorespiratory fitness for prediction of mortality and multisystem disease risks (Photo courtesy of Perry, A.S., Farber-Eger, E., Gonzales, T. et al.; doi.org/10.1038/s41591-024-03039-x)

Cardiorespiratory fitness significantly influences various bodily systems, from metabolism to brain function. Currently, there is no standardized method to quantitatively assess cardiorespiratory fitness, even though it provides a comprehensive view of a person’s health. Now, a new study has found that levels of circulating proteins could be effective biomarkers for cardiorespiratory fitness, a crucial but previously difficult-to-quantify component of an individual’s overall health.

In the study published in Nature Medicine, investigators at Northwestern University Feinberg School of Medicine (Chicago, IL, USA) used statistical models to identify circulating proteins that most significantly affect overall health across over 14,000 participants. The researchers developed a cardiorespiratory fitness score based on an individual's levels of certain circulating proteins, which are linked to inflammation, neuronal survival and growth, and oxidative stress, among other factors. This scoring system was then validated using data from 20,000 individuals in the UK Biobank, revealing that a favorable score correlates with a lower risk of all-cause mortality.

The team further tested the validity of their scoring system by analyzing the circulating proteins of over 600 individuals before and after they participated in a 20-week exercise program. The study found that improvements in participants' cardiorespiratory fitness scores were associated with the beneficial impacts of exercise on their cardiorespiratory systems. These results establish a foundation for a scoring system that could potentially assess holistic health through a simple blood test, offering insights into the relationship between fitness and health. Building on this, the researchers plan to extend this protein scoring method to additional areas of overall health.

“We know a lot about trajectories of health. Someone might be on a declining trajectory, but when we see patients at one time point, it’s really hard for us to extrapolate what a trajectory of someone’s health may be,” said Ravi Kalhan, MD, MS, professor of Medicine in the Division of Pulmonary and Critical Care, of Preventive Medicine in the Division of Epidemiology, and a co-author of the study. “If we could apply these single-time-point measurements using a blood test that reflects a greater, more difficult-to-ascertain factor of health, that really would be interesting.”

Related Links:
Northwestern University Feinberg School of Medicine

New
Gold Member
RPR and TPLA Assays
SEKURE RPR and TPLA Assays
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Chemiluminescence Immunoassay Analyzer
Shine i3000
New
Multiplexing System
MAGPIX® System

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The new platelet-centric scoring system predicts platelet hyperreactivity and related risk of cardiovascular events (Photo courtesy of Shutterstock)

Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke

Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
A schematic of the 3D MM imaging experimental setup used in the studies of blood films (Photo courtesy of Ushenko, A.G., et al.; doi.org/10.1038/s41598-024-63816-z)

Novel Light-Based Technique With 90% Accuracy Rate to Revolutionize Cancer Diagnosis

A quicker, cheaper, and less painful cancer detection technique developed using light has the potential to revolutionize cancer diagnosis, early detection, and monitoring. Researchers at Aston Institute... Read more

Industry

view channel
Image: The QIAstat-Dx IVD panel for neurodegenerative applications will be integrated with the QIAstat-Dx multiplex testing platform (Photo courtesy of QIAGEN)

Qiagen and Eli Lilly to Develop First QIAstat-Dx IVD Panel for Neurodegenerative Applications

QIAGEN N.V. (Venlo, the Netherlands) has entered into a collaboration with Eli Lilly and Company (Indianapolis, IN, USA) to support the development of a QIAstat-Dx in-vitro diagnostic (IVD) to detect APOE genotypes.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.